Annora Pharma`s Generic Colchicine Receives Tentative ApprovalApprovals in the U.S
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Gout is a painful arthritic disorder affecting...
Takeda has managed to close one of the antitrust cases that have been hanging over the company.
Micro Labs' Generic Colchicine Receives Approval in US
PARSIPPANY, N.J.--(BUSINESS WIRE)--AGEPHA Pharma USA, LLC, today announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved LODOCO® as the first anti-inflammatory atheroprotective cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease.1
Enforcement Report - Week of March 22, 2023
Annora's Generic Colchicine Receives Approval in the U.S.
Barcelona, Spain – 29 Aug 2022: A randomised trial in nearly 4,000 outpatients with COVID-19 has found no benefit of treatment with aspirin or colchicine. The late breaking research is presented in a Hot Line session today at ESC Congress 2022.1
Barcelona, Spain – 29 Aug 2022: A randomised trial in hospitalised COVID-19 patients has found no benefit of treatment with colchicine or the combination of aspirin and rivaroxaban. The late breaking research is presented in a Hot Line session today at ESC Congress 2022.1
Strides Pharma Gets USFDA Nod for Colchicine Tablets